Komipharm International Co., Ltd. (KOSDAQ: 041960)

Komipharm International Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	12,143	14,820	10,805	11,992	15,048	18,879
Short-Term Investments	-0	-0	-	23.08	2,057	2,046
Trading Asset Securities	-	-	-	1,914	-	-
Cash & Short-Term Investments	12,143	14,820	10,805	13,929	17,106	20,924
Cash Growth	-9.32%	37.16%	-22.43%	-18.57%	-18.25%	-5.69%
Accounts Receivable	17,518	12,042	10,849	9,858	10,991	11,286
Other Receivables	62.26	47.67	25.07	150.49	225.26	226.91
Receivables	23,722	17,901	13,984	12,848	12,963	13,213
Inventory	14,357	14,901	16,254	14,176	13,837	12,267
Prepaid Expenses	1,582	1,723	327.35	183.49	145.63	135.6
Other Current Assets	1,657	667.43	221.76	315.9	624.05	368.7
Total Current Assets	53,460	50,012	41,593	41,452	44,675	46,909
Property, Plant & Equipment	57,940	64,239	66,522	70,141	72,063	73,702
Long-Term Investments	1,562	2,619	1,223	2,220	4,320	3,943
Other Intangible Assets	2,047	42.46	54.76	62.17	68.42	73.69
Long-Term Accounts Receivable	-	-	-	0	-	-
Long-Term Deferred Charges	1,364	1,172	753.46	847.1	616.92	753.71
Other Long-Term Assets	6,634	470.07	1,579	539.54	169.24	183.24
Total Assets	123,044	118,598	111,751	115,262	121,913	125,644
Accounts Payable	5,115	2,615	3,746	2,756	3,367	3,650
Accrued Expenses	452.6	437.59	274.77	329.23	283.02	270.54
Short-Term Debt	24,900	21,100	21,500	19,500	31,043	23,838
Current Portion of Long-Term Debt	12,247	19,162	13,141	731.05	1,731	731.09
Current Portion of Leases	214.82	245.64	174.68	154.46	160.86	213.59
Other Current Liabilities	8,292	8,668	2,211	2,213	2,752	2,333
Total Current Liabilities	51,222	52,228	41,047	25,685	39,338	31,035
Long-Term Debt	6,126	4,326	3,057	12,798	2,519	15,955
Long-Term Leases	191.18	267.91	258.85	237.84	214.54	161.8
Long-Term Deferred Tax Liabilities	1,761	1,761	1,741	1,741	1,741	1,744
Other Long-Term Liabilities	-	0	0	2,394	-	583.05
Total Liabilities	59,299	58,583	46,104	42,856	43,812	49,479
Common Stock	7,060	7,060	6,419	6,419	6,419	6,392
Additional Paid-In Capital	73,138	73,874	80,279	78,807	84,993	95,495
Retained Earnings	-17,924	-23,783	-24,804	-18,290	-13,831	-27,018
Treasury Stock	-4,221	-2,052	-1,989	-989.46	-989.46	-989.46
Comprensive Income & Other	2,193	1,238	725.91	513.98	-315.96	-604.59
Total Common Equity	60,247	56,338	60,631	66,460	76,275	73,276
Minority Interest	3,498	3,677	5,016	5,946	1,825	2,890
Shareholders' Equity	63,745	60,015	65,647	72,406	78,101	76,166
Total Liabilities & Equity	123,044	118,598	111,751	115,262	121,913	125,644
Total Debt	43,679	45,102	38,131	33,422	35,668	40,899
Net Cash (Debt)	-31,536	-30,282	-27,327	-19,493	-18,563	-19,975
Net Cash Per Share	-449.79	-431.66	-388.82	-277.38	-264.39	-285.54
Filing Date Shares Outstanding	69.63	70.15	70.12	70.28	70.28	69.99
Total Common Shares Outstanding	69.63	70.15	70.12	70.28	70.28	69.99
Working Capital	2,238	-2,217	545.11	15,768	5,337	15,874
Book Value Per Share	865.25	803.07	864.66	945.70	1085.37	1046.97
Tangible Book Value	58,200	56,295	60,576	66,398	76,207	73,202
Tangible Book Value Per Share	835.86	802.46	863.88	944.81	1084.39	1045.91
Land	14,149	17,998	17,903	18,678	18,561	18,485
Buildings	42,147	44,444	44,337	44,359	44,029	43,768
Machinery	25,967	25,514	25,146	24,625	24,231	23,978
Construction In Progress	11,329	10,804	10,719	10,719	10,361	9,468

Source: S&P Capital IQ. Standard template. Financial Sources.